- Coronavirus, experts on Nature: "Rash Russian vaccine"
- Coronavirus, Putin: "Russia has registered the first vaccine"
- At Spallanzani the first doses of the vaccine made in Italy
- Covid, Aifa authorizes Italian ReiThera vaccine test
Share12 August 2020 "The manifestation of public interest of the National Institute for Infectious Diseases, Lazzaro Spallanzani of Rome for the search for volunteers for the experimentation of the COVID-19 vaccine has exceeded 4 thousand subscriptions. An extraordinary response that fills with pride". This was declared by the Councilor for Health of the Lazio Region, Alessio D'Amato.
According to the latest medical bulletin, 52 patients are hospitalized at Spallanzani in Rome. Of these, 42 are positive for the swab for Sars-Cov-2, 10 are subjected to investigations. The number of patients in need of intensive care has risen to 3. The patients discharged and transferred to their homes or to other territorial structures remain 577 this morning.